A recent study on resistance to an analog of vemurafinib, PLX4720, suggested that only in cell lines with PTEN deletion p-AKT is induced by this BRAF inhibitor, and lack of PTEN may play a role in preventing apoptosis of melanoma cell treated with this compound [24]. This evidence concerns the gene AKT1 and melanoma.